Abstract
Timely and accurate diagnosis of Shiga toxigenic Escherichia coli (STEC) disease in humans is extremely important from both a public health and a clinical management perspective. In the outbreak setting, rapid diagnosis of cases and immediate notification of health authorities is essential for effective epidemiological intervention. Early diagnosis also creates a window of opportunity for therapeutic intervention. Agents capable of adsorbing and neutralizing free Shiga toxin (Stx) in the gut lumen have been described (1,2), and these are likely to be most effective when adminstered early in the course of disease, before serious systemic sequelae develop. Also, the clinical presentation of STEC disease can sometimes be confused with other bowel conditions; thus, early definitive diagnosis may prevent unnecessary invasive and expensive surgical and investigative procedures or administation of antibiotic therapy, which may be contraindicated (3). However, detection of STEC is fraught with difficulty, particularly for strains belonging to serogroups other than O157. In the early stages of infection, there may be very high numbers of STEC in feces (the STEC may constitute >90% of aerobic flora), but as disease progresses, the numbers may drop dramatically. In cases of hemolytic uraemic syndrome (HUS), the typical clinical signs may become apparent as much as 2 wk after the onset of gastrointestinal symptoms, by which time the numbers of the causative STEC may be very low indeed. Also, in some cases, diarrhea is no longer present and only a rectal swab may be available at the time of admission to the hospital, limiting the amount of specimen available for analysis. For these reasons, STEC detection methods need to be very sensitive and require minimal specimen volumes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Armstrong G. D., Rowe P. C., Goodyer P., Orrbine E., Klassen T. P., Wells G., et al. (1995) A phase I study of chemically synthesized verotoxin (Shiga-like toxin) Pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J. Infect. Dis. 171, 1042ā1045.
Paton A. W., Morona R., and Paton J. C. (2000) A new biological agent for treatment of Shiga toxigenic Escherichia coli infections and dysentery in humans. Nat. Med. 6, 265ā270.
Tarr P. I. (1995) Escherichia coli O157:H7 clinical, diagnostic, and epidemiological aspects of human infection. Clin. Infect. Dis. 20, 1ā8.
Karmali M. A. (1989) Infection by verocytotoxin-producing Escherichia coli. Clin. Microbiol. Rev. 2, 15ā38.
Paton J. C. and Paton A. W. (1998) Pathogenesis and diagnosis of Shiga toxinproducing Escherichia coli infections. Clin. Microbiol. Rev. 11, 450ā479.
Strockbine N. A., Wells J. G., Bopp C. A., and Barrett T.J. (1998) Overview of detection and subtyping methods, in Escherichia coli O157:H7 and Other Shiga Toxin-Producing E. coli Strains (Kaper J. B. and OāBrien A. D. eds.), American Society for Microbiology Washington, DC, pp. 331ā356.
Karch H., Bielaszewska M., Bitzan M., and Schmidt H. (1999) Epidemiology and diagnosis of Shiga toxin-producing Escherichia coli infections. Diagn. Microbiol. Infect. Dis. 34, 229ā243.
Karmali M. A., Petric M., Lim C., Cheung R., and Arbus G. S. (1985) Sensitive method for detecting low numbers of verotoxin-producing Escherichia coli in mixed cultures by use of colony sweeps and polymyxin extraction of verotoxin. J. Clin. Microbiol. 22, 614ā619.
Ashkenazi S. and Cleary T. G. (1990) A method for detecting Shiga toxin and Shiga-like toxin-I in pure and mixed culture. J. Med. Microbiol. 32, 255ā261.
Law D., Ganguli L. A., Donohue-Rolfe A., and Acheson D. W. (1992) Detection by ELISA of low numbers of Shiga-like toxin-producing Escherichia coli in mixed cultures after growth in the presence of mitomycin C. J. Med. Microbiol. 36, 198ā202.
Kehl K. S., Havens P., Behnke C. E., and Acheson D. W. K. (1997) Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 35, 2051ā2054.
Mackenzie A. M. R., Lebel P., Orrbine E., Rowe P. C., Hyde L., Chan F., et al., and the Synsorb PK Study Investigators (1998) Sensitivities and specificities of Premier E. coli O157 and Premier EHEC enzyme immunoassays for diagnosis of infection with verotoxin (Shiga-like toxin)-producing Escherichia coli. J. Clin. Microbiol. 36, 1608ā1611.
Beutin L., Zimmermann S., and Gleier K. (1996) Rapid detection and isolation of Shiga-like toxin (Verocytotoxin)-producing Escherichia coli by direct testing of individual enterohemolytic colonies from washed sheep blood agar plates in the VTEC-RPLA assay. J. Clin. Microbiol. 34, 2812ā2814.
Karmali M. A., Petric M., and Bielaszewska M. (1999) Evaluation of a microplate latex agglutination method (Verotox-F assay) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli. J. Clin. Microbiol. 37, 396ā399.
Thomas A., Smith H. R., Willshaw G. A., and Rowe B. (1991) Non-radioactively labelled polynucleotide and oligonucleotide DNA probes, for selectively detecting Escherichia coli strains producing Vero cytotoxins VT1, VT2 and VT2 variant. Mol. Cell. Probes 5, 129ā135.
Begum D., Strockbine N. A., Sowers E. G., and Jackson M. P. (1993) Evaluation of a technique for identification of Shiga-like toxin-producing Escherichia coli by using polymerase chain reaction and digoxigenin-labeled probes. J. Clin. Microbiol. 31, 3153ā3156.
Brian M. J., Frosolono M., Murray B. E., Miranda A., Lopez E. L., Gomez H. F., and Cleary T. G. (1992) Polymerase chain reaction for diagnosis of enterohemorrhagic Escherichia coli infection and hemolytic-uremic syndrome. J. Clin. Microbiol. 30, 1801ā1806.
Gannon V. P. J., King R. K., Kim J. Y., and Thomas E. J. (1992) Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction. Appl. Environ. Microbiol. 58, 3809ā3815.
Pollard D. R., Johnson W. M., Lior H., Tyler S. D., and Rozee K. R. (1990) Rapid and specific detection of verotoxin genes in Escherichia coli by the polymerase chain reaction. J. Clin. Microbiol. 28, 540ā545.
Karch H. and Meyer T. (1989) Single primer pair for amplifying segments of distinct Shiga-like toxin genes by polymerase chain reaction. J. Clin. Microbiol. 27, 2751ā2757.
Paton A. W., Paton J. C., Goldwater P. N., and Manning P. A. (1993) Direct detection of Escherichia coli Shiga-like toxin genes in primary fecal cultures by polymerase chain reaction. J. Clin. Microbiol. 31, 3063ā3067.
Lin Z., Kurazono H., Yamasaki S., and Takeda Y. (1993) Detection of various variant verotoxin genes in Escherichia coli by polymerase chain reaction. Microbiol. Immunol. 37, 543ā548.
Russmann H., Schmidt H., Heesemann J., Caprioli A., and Karch H. (1994) Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome. J. Med. Microbiol. 40, 338ā343.
Tyler S. D., Johnson W. M., Lior H., Wang G., and Rozee K. R. (1991) Identification of verotoxin type 2 variant B subunit genes in Escherichia coli by the polymerase chain reaction and restriction fragment length polymorphism analysis. J. Clin. Microbiol. 29, 1339ā1343.
Chen S., Xu R., Yee A., Wu K. Y., Wang C. N., Read S., et al. (1998) An automated fluorescent PCR method for detection of shiga toxin-producing Escherichia coli in foods. Appl. Environ. Microbiol. 64, 4210ā4216.
Sharma V. K., Dean-Nystrom E. A., and Casey T. A. (1999) Semi-automated fluorogenic PCR assays (TaqMan) for rapid detection of Escherichia coli O157:H7 and other Shiga toxigenic E. coli. Mol. Cell. Probes 13, 291ā302.
Gannon V.P.J., Rashed M., King R.K., and Thomas E.J.G. (1993) Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction. J. Clin. Microbiol. 31, 1268ā1274.
Schmidt H., Beutin L., and Karch H. (1995) Molecular analysis of the plasmidencoded hemolysin of Escherichia coli O157:H7 strain EDL 933. Infect. Immun. 63, 1055ā1061.
Barrett T. J., Kaper J. B., Jerse A. E., and Wachsmuth I. K. (1992) Virulence factors in Shiga-like toxin-producing Escherichia coli isolated from humans and cattle. J. Infect. Dis. 165, 979ā980.
Schmidt H. and Karch H. (1996) Enterohemolytic phenotypes and genotypes of Shiga toxin-producing Escherichia coli O111 strains from patients with diarrhea and hemolytic-uremic syndrome. J. Clin. Microbiol. 34, 2364ā2367.
Louie M., De-Azavedo J., Clarke R., Borczyk A., Lior H., Richter M., et al. (1994) Sequence heterogeneity of the eae gene and detection of verotoxin-producing Escherichia coli using serotype-specific primers. Epidemiol. Infect. 112, 449ā461.
Paton A. W. and Paton J. C. (1998) Detection and characterization of Shiga toxigenic Escherichia coli using multiplex PCR assays for stx1, stx2, eaeA, Enterohemorrhagic E. coli hlyA, rfbO111 and rfbO157. J. Clin. Microbiol. 36, 598ā602.
Paton A. W. and Paton J. C. (1999) Direct detection of Shiga toxigenic Escherichia coli strains belonging to serogroups O111, O157, and O113 by multiplex PCR. J. Clin. Microbiol. 37, 3362ā3365.
Gannon V. P. J., DāSouza S., Graham T., King R. K., Rahn K., and Read S. (1997) Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity and identification of enterohemorrhagic Escherichia coli strains. J. Clin. Microbiol. 35, 656ā662.
Cebula T. A., Payne W. L., and Feng P. (1995) Simultaneous identification of strains of Escherichia coli serotype O157:H7 and their Shiga-like toxin type by mismatch amplification mutation assay-multiplex PCR. J. Clin. Microbiol. 33, 248ā250. [Published erratum appears in J. Clin. Microbiol. 33, 1048.]
March S. B. and Ratnam S. (1986) Sorbitol-MacConkey medium for detection of Escherichia coli O157:H7 associated with hemorrhagic colitis. J. Clin. Microbiol. 23, 869ā872.
Chapman P. A., Siddons C. A., Zadik P. M., and Jewes L. (1991) An improved selective medium for the isolation of Escherichia coli O157. J. Med. Microbiol. 35, 107ā110.
Zadik P. M., Chapman P. A., and Siddons C. A. (1993) Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. J. Med. Microbiol. 39, 155ā158.
Gunzer F., Bohm H., Russmann H., Bitzan M., Aleksic S., and Karch H. (1992) Molecular detection of sorbitol-fermenting Escherichia coli O157 in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 30, 1807ā1810.
Bielaszewska M., Janda J., Blahova K., Karch H., Karmali M. A., Preston M. A., et al. (1997) Isolation of sorbitol-fermenting (SF) verocytotoxin-producing Escherichia coli O157:H-in the Czech Republic. 13rd International Symposium and Workshop on Shiga Toxin (Verotoxin)-producing Escherichia coli Infections, Baltimore, MD.
Ratnam S., March S. B., Ahmed R., Bezanson G. S., and Kasatiya S. (1988) Characterization of Escherichia coli serotype O157:H7. J. Clin. Microbiol. 26, 2006ā2012.
Thompson J. S., Hodge D. S., and Borczyk A. A. (1990) Rapid biochemical test to identify verocytotoxin-positive strains of Escherichia coli serotype O157. J. Clin. Microbiol. 28, 2165ā2168.
Novicki T.J., Daly J.A., Mottice S.L., and Carroll K.C. (2000) Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli. J. Clin. Microbiol. 38, 547ā551.
Park C.H., Hixon D.L., Morrison W.L., and Cook C.B. (1994) Rapid diagnosis of enterohemorrhagic Escherichia coli O157:H7 directly from fecal specimens using immunofluorescence stain. Am. J. Clin. Pathol. 101, 91ā94.
Park C. H., Vandel N. M., and Hixon D. L. (1996) Rapid immunoassay for detection of Escherichia coli O157 directly from stool specimens. J. Clin. Microbiol. 34, 988ā990.
Beutin L., Montenegro M. A., Orskov I., Orskov F., Prada J., Zimmermann S., et al. (1989) Close association of verotoxin (Shiga-like toxin) production with enterohemolysin production in strains of Escherichia coli. J. Clin. Microbiol. 27, 2559ā2564.
Hull A. E., Acheson D. W., Echeverria P., Donohue-Rolfe A., and Keusch G. T. (1993) Mitomycin immunoblot colony assay for detection of Shiga-like toxinproducing Escherichia coli in fecal samples: comparison with DNA probes. J. Clin. Microbiol. 31, 1167ā1172.
Chapman P. A. and Siddons C. A. (1996) A comparison of immunomagnetic separation and direct culture for the isolation of verocytotoxin-producing Escherichia coli O157 from cases of bloody diarrhoea, non-bloody diarrhoea and asymptomatic contacts. J. Med. Microbiol. 44, 267ā271.
Karch H., Janetzki-Mittmann C., Aleksic S., and Datz M. (1996) Isolation of enterohemorrhagic Escherichia coli O157 strains from patients with hemolyticuremic syndrome by using immunomagnetic separation, DNA-based methods and direct culture. J. Clin. Microbiol. 34, 516ā519.
Paton A. W., Ratcliff R., Doyle R. M., Seymour-Murray J., Davos D., Lanser J. A., et al. (1996) Molecular microbiological investigation of an outbreak of hemolytic uremic syndrome caused by dry fermented sausage contaminated with Shiga-like toxin-producing Escherichia coli. J. Clin. Microbiol. 34, 1622ā1627.
Jenkins C., Chart H., Smith H.R., Hartland E.L., Batchelor M., Delahay R.M., et al. (2000) Antibody response of patients infected with verocytotoxin-producing Escherichia coli to protein antigens encoded on the LEE locus. J. Med. Microbiol. 49, 97ā101.
Barrett T. J., Green J. H., Griffin P. M., Pavia A. T., Ostroff S. M., and Wachsmuth I. K. (1991) Enzyme-linked immunosorbent assays for detecting antibodies to Shiga-like toxin I, Shiga-like toxin II, and Escherichia coli O157:H7 lipopolysaccharide in human serum. Curr. Microbiol. 23, 189ā195.
Chart H., Law D., Rowe B., and Acheson D. W. (1993) Patients with haemolytic uraemic syndrome caused by Escherichia coli O157: absence of antibodies to Vero cytotoxin 1 (VT1) or VT2. J. Clin. Pathol. 46, 1053,1054.
Karmali M. A., Petric M., Winkler M., Bielaszewska M., Brunton J., van-de-Kar N., et al. (1994) Enzyme-linked immunosorbent assay for detection of immunoglobulin G antibodies to Escherichia coli Vero cytotoxin 1. J. Clin. Microbiol. 32, 1457ā1463.
Reymond D., Karmali M. A., Clarke I., Winkler M., and Petric M. (1997) Comparison of the western blot assay with the neutralizing-antibody and enzymelinked immunosorbent assays for measuring antibody to verocytotoxin 1. J. Clin. Microbiol. 35, 609ā613.
Bitzan M. and Karch H. (1992) Indirect hemagglutination assay for diagnosis of Escherichia coli O157 infection in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 30, 1174ā1178.
Bitzan M., Moebius E., Ludwig K., Muller-Wiefel D. E., Heesemann J., and Karch H. (1991) High incidence of serum antibodies to Escherichia coli O157 lipopolysaccharide in children with hemolytic-uremic syndrome. J. Pediatr. 119, 380ā385.
Chart H., Smith H. R., Scotland S. M., Rowe B., Milford D. V., and Taylor C. M. (1991) Serological identification of Escherichia coli infection in haemolytic uraemic syndrome. Lancet 337, 138ā140.
Greatorex J. S. and Thorne G.M. (1994) Humoral immune responses to Shigalike toxins and Escherichia coli O157 lipopolysaccharide in hemolytic-uremic syndrome patients and healthy subjects. J. Clin. Microbiol. 32, 1172ā1178.
Yamada S., Kai A., and Kudoh Y. (1994) Serodiagnosis by passive hemagglutination test and verotoxin enzyme-linked immunosorbent assay of toxin-producing Escherichia coli infections in patients with hemolytic-uremic syndrome. J. Clin. Microbiol. 32, 955ā959.
Chart H. (1999) Evaluation of a latex agglutination kit for the detection of human antibodies to the lipopolysaccharide of Escherichia coli O157, following infection with verocytotoxin-producing E. coli O157. Lett. Appl. Microbiol. 29, 434ā436.
Bielaszewska M., Janda J., Blahova K., Feber J., Potuznik V., and Souckova A. (1996) Verocytotoxin-producing Escherichia coli in children with hemolytic uremic syndrome in the Czech Republic. Clin. Nephrol. 46, 42ā44.
Chart H. and Rowe B. (1990) Serological identification of infection by Vero cytotoxin producing Escherichia coli in patients with haemolytic uraemic syndrome. Serodiagn. Immunother. Infect. Dis. 4, 413ā418.
Caprioli A., Luzzi I., Rosmini F., Resti C., Edefonti A., Perfumo F., et al. (1994) Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J. Infect. Dis. 169, 208ā211.
Paton A. W., Woodrow M. C., Doyle R. M., Lanser J. A. and Paton J. C. (1999) Molecular characterization of a Shiga-toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J. Clin. Microbiol. 37, 3357ā3361.
Karch H., Meyer T., Russmann H., and Heesemann J. (1992) Frequent loss of Shiga-like toxin genes in clinical isolates of Escherichia coli upon subcultivation. Infect. Immun. 60, 3464ā3467.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Paton, J.C., Paton, A.W. (2003). Methods for Detection of STEC in Humans. In: Philpott, D., Ebel, F. (eds) E. coli. Methods in Molecular Medicineā¢, vol 73. Humana Press. https://doi.org/10.1385/1-59259-316-X:09
Download citation
DOI: https://doi.org/10.1385/1-59259-316-X:09
Publisher Name: Humana Press
Print ISBN: 978-0-89603-939-1
Online ISBN: 978-1-59259-316-3
eBook Packages: Springer Protocols